A phase II study of the c-Met inhibitor tivantinib (tiv) in combination with FOLFOX for the treatment of patients (pts) with previously untreated metastatic adenocarcinoma of the distal esophagus, gastroesophageal (GE) junction, or stomach

Abstract only

Saved in:

Bibliographic Details
Published in:	Journal of clinical oncology Vol. 33; no. 15_suppl; p. 4065
Main Authors:	Pant, Shubham, Patel, Manish R., Kurkjian, Carla, Hemphill, Michael Brian, Flores, Maria Regina C., Thompson, Dana Shelton, Bendell, Johanna C.
Format:	Journal Article
Language:	English
Published:	20-05-2015
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!